种系突变异常的临床试验
总计1905个结果
-
University of Chicago招聘中
-
National Taiwan University Hospital完全的
-
Massachusetts General HospitalAgios Pharmaceuticals, Inc.完全的
-
NYU Langone Health撤销乳腺癌 | BRCA1突变 | BRCA2突变美国
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.招聘中非小细胞肺癌 | BRAF V600突变 | MET扩增 | MET 外显子 14 跳跃突变 | RET驱动突变 | Erb-B2 受体酪氨酸激酶外显子 20 突变中国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人BRCA1基因突变 | BRCA2基因突变 | 转移性恶性肿瘤 | 晚期恶性肿瘤 | 复发性恶性肿瘤 | 难治性恶性肿瘤 | PALB2基因突变 | ATM基因突变美国
-
Ohio State University Comprehensive Cancer CenterUniversity of Michigan完全的
-
Shandong UniversityFudan University; Chinese Nutrition Society暂停
-
Boehringer Ingelheim主动,不招人
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre; Takeda Canada,... 和其他合作者招聘中癌症 | 多发性恶性肿瘤 | 恶性实体瘤 | 癌症,治疗相关 | 分子序列变异 | 遗传改变 | 基因融合 | 受体酪氨酸激酶基因突变 | RTK家族基因突变 | Ras(Kras 或 Nras)基因突变加拿大
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); ChiRhoClin, Inc.招聘中
-
Jessa HospitalHasselt University; Ziekenhuis Oost-Limburg招聘中
-
Royal Marsden NHS Foundation Trust完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Groupe Hospitalier Pitie-SalpetriereInstitut National de la Santé Et de la Recherche Médicale, France完全的
-
Shirley Ryan AbilityLabUniversity of Alberta招聘中
-
ITAB - Institute for Advanced Biomedical TechnologiesItalian Society of Cardiology完全的
-
Cairo University未知Augmentation of Maxillary Horizontal And Vertical Bone Deficiency Using Mineralized Plasmatic MatrixAlveolar Ridge Abnormality of Maxilla埃及
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Worcester...完全的
-
Georgetown UniversityImmune System Key Ltd招聘中
-
Istituto Clinico HumanitasCelgene未知
-
Centre Hospitalier Universitaire de Besancon完全的
-
Ruijin Hospital招聘中
-
Blueprint Medicines Corporation完全的全身肥大细胞激活 | KIT D816V突变美国, 法国, 英国, 意大利, 德国, 比利时, 西班牙, 瑞士
-
Hubei Biological Medicine Industrial Technology...未知
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)主动,不招人
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.尚未招聘BRCA1突变 | BRCA2突变 | PALB2基因突变 | 激素受体阳性 HER-2 阴性乳腺癌 | 晚期或转移性乳腺癌德国
-
Intergroupe Francophone de Cancerologie Thoracique完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知乳腺癌 | brca1突变携带者 | brca2突变携带者美国
-
AstraZeneca完全的
-
Calithera Biosciences, Inc完全的